Matinas BioPharma
MTNB
MTNB
45 hedge funds and large institutions have $8.74M invested in Matinas BioPharma in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$344K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.7K |
| 3 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$23K |
| 4 |
Citigroup
New York
|
+$18.5K |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.9K |
Top Sellers
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$155K |
| 2 |
VF
Virtu Financial
New York
|
-$123K |
| 3 |
SG Americas Securities
New York
|
-$50K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$44.4K |
| 5 |
Goldman Sachs
New York
|
-$30.5K |
